Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|June 17, 1998
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion developmentF Samaniego, P D Markham, R Gendelman, et al.
Genes, Chromosomes & Cancer|March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplificationF Samaniego, E Rodriguez, J Houldsworth, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 1, 1992
An iron-sulfur cluster plays a novel regulatory role in the iron-responsive element binding proteinT A Rouault, D J Haile, W E Downey, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Cloning of the cDNA encoding an RNA regulatory protein--the human iron-responsive element-binding proteinT A Rouault, C K Tang, S Kaptain, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Nature|May 4, 1995
Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormoneY Lunardi-Iskandar, J L Bryant, R A Zeman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphomaB Esmaeli, P McLaughlin, B Pro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2007
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphomaM J Overman, L Feng, B Pro, et al.
Leukemia|July 11, 2017
Targeting nucleolin for better survival in diffuse large B-cell lymphomaN Jain, H Zhu, T Khashab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomesC Y Cheah, D Chihara, S Horowitz, et al.
Pageof 5